Ketones, omega-3 fatty acids and the Yin-Yang balance in the brain: insights from infant development and Alzheimer's disease, and implications for human brain evolution

被引:6
|
作者
Cunnane, Stephen C. [1 ]
机构
[1] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
brain; brain development; Alzheimer's disease; glucose; ketones; beta-hydroxybutyrate; aging; omega-3 fatty acids; alpha-linolenic acid; eicosapentaenoic acid; docosahexaneoic acid;
D O I
10.1051/ocl/2018020
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Optimal brain performance is intimately linked to the brain's Yin and the Yang - the balance between its structure and its energy metabolism. This relationship is clearly exemplified in infant brain development and in Alzheimer's disease, and probably also applies to human brain evolution. In these examples, redundant pathways help achieve this important balance. For instance, the key structural lipid for the brain, docosahexaenoic acid (DHA), is supplied to the infant brain from at last three overlapping sources: (i) milk; (ii) infant's own fat stores and (iii) by some endogenous synthesis from alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA). On the energy side, glucose is normally the brain's main fuel but under conditions of prolonged starvation, it can be almost totally replaced by the ketone bodies, acetoacetate and beta-hydroxybutyrate. When ketones are present in the blood they spare glucose uptake by the brain because they are actually the brain's preferred fuel and are essential for normal infant brain development. The redundant sources of ketones are long chain fatty acids (including the relatively ketogenic ALA) in infant stores, and medium chain triglycerides (MCT) in milk. Besides infancy, nowhere is the strain on the brain's balance between yin and yang more apparent than in Alzheimer's disease (AD). One of the reasons why attempts to treat AD have largely failed could well be because chronically inadequate glucose supply to some areas of the brain on the order of 10% is present in people at risk of AD long before cognitive decline begins. However, brain ketone uptake is still normal even in moderately advanced AD. Hence, treatments that ignore the brain energy (glucose) deficit in AD would be predicted to fail, but treatments that attempt to rescue brain fuel availability via ketones would be predicted to have a better chance of succeeding. By analogy to ketones sparing glucose for brain energy metabolism, perhaps ALA or EPA entering the brain can help spare (conserve) DHA for its structural role. If so, it would not necessarily be futile to transport ALA and EPA into the brain just to beta-oxidize the majority afterwards; DHA sparing as well as ketone production could be important beneficiaries.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease
    Casali, Brad T.
    Corona, Angela W.
    Mariani, Monica M.
    Karlo, J. Colleen
    Ghosal, Kaushik
    Landreth, Gary E.
    JOURNAL OF NEUROSCIENCE, 2015, 35 (24): : 9173 - 9181
  • [32] ARE OMEGA-3-FATTY-ACIDS REQUIRED FOR NORMAL EYE AND BRAIN-DEVELOPMENT IN THE HUMAN
    UAUY, R
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1990, 11 (03): : 296 - 302
  • [33] Curcumin and omega-3 polyunsaturated fatty acids as bioactive food components with synergistic effects on Alzheimer's disease
    Velasco-Rodriguez, Luz del C.
    Garcia, Hugo S.
    Rascon-Diaz, Martha P.
    PSYCHOGERIATRICS, 2024, 24 (03) : 701 - 718
  • [34] Cognitive efficacy of omega-3 fatty acids in Alzheimer's disease: A systematic review and meta-analysis
    Kalamara, Tsampika Vasileia
    Dodos, Konstantinos
    Georgakopoulou, Vasiliki Epameinondas
    Fotakopoulos, George
    Spandidos, Demetrios A.
    Kapoukranidou, Dorothea
    BIOMEDICAL REPORTS, 2025, 22 (04)
  • [35] Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses
    Rouch, Laure
    Giudici, Kelly Virecoulon
    Cantet, Christelle
    Guyonnet, Sophie
    Delrieu, Julien
    Legrand, Philippe
    Catheline, Daniel
    Andrieu, Sandrine
    Weiner, Michael
    Barreto, Philipe de Souto
    Vellas, Bruno
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2022, 116 (06): : 1492 - 1506
  • [36] Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model
    Pandiyan Arunagiri
    Elumalai Balamurugan
    Murugesan Saravanakumar
    Mackraj Irene
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2018, 391 : 335 - 346
  • [37] KEY ROLE OF OMEGA-3 AND OMEGA-6 FATTY ACIDS IN HUMAN BIOLOGY; CRAWFORD'S PREDICTIVE THEORY OF EVOLUTION
    Kochman, Kazimierz
    POSTEPY BIOLOGII KOMORKI, 2012, 39 (02) : 189 - 198
  • [38] Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model
    Arunagiri, Pandiyan
    Balamurugan, Elumalai
    Saravanakumar, Murugesan
    Irene, Mackraj
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 (03) : 335 - 346
  • [39] THE JOINT ROLES OF XANTHOPHYLLS AND OMEGA-3 FATTY ACIDS IN MACULAR DISEASE: INSIGHTS FROM A NONHUMAN PRIMATE MODEL
    Neuringer, M.
    Renner, L.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (04) : 606 - 606
  • [40] Insights from a proteomic atlas of human Alzheimer's disease brain tissue
    Tomas Kavanagh
    Eleanor Drummond
    Neural Regeneration Research, 2025, (03) : 799 - 800